Moderna (NASDAQ: MRNA) Shares Of 5,000 Sold By Insider


Tal Zvi Zaks is an insider of Moderna (NASDAQ: MRNA). Recently on 19th May, Wednesday, he sold 5,000 MRNA shares at $155.74 EPS worth $778,700.

On Thursday, Moderna Inc. traded up at $7.98 and hit $165.97 with the market cap being $66.64 billion. They had 4,829,061 trading volumes in comparison to 11,456,525 average volumes. Their lowest in 52 weeks is $46.13 while the highest is $189.26. Their 50-day rolling average stands at $157.56 while the 200 days at $139.47. Their current, quick, and leverage ratio is 2.43, 2.43, and 0.04, respectively.

According to their 6th May report, the firm had a quarterly EPS of $2.84, topping the $2.04 consensus estimate by almost $0.80. They had a 242.73% net negative margin along with a 28.11% negative equity return. Their revenue was $1.94 billion, falling short of the $2.48 billion estimates.

Market Undertakings Of MRNA Stock

Barclays upgraded the price objective of MRNA shares to $194 from $178 and gave a rating of ‘overweight’. SVB Leerink reassigned the rating of ‘sell’. Chardan Capital lifted it to $188 from $182 and gave a rating of ‘buy’. Needham & Co reinstated the rating of ‘hold’. Piper Sandler demoted it to $231 from 234 and gave a rating of ‘overweight’. The firm has the consensus ‘hold’ recommendation with a $162.88 price objective.

Baillie Gifford and Co increased their holdings on Moderna stock by nearly 86.5% and own $5,936,980,000 worth of stock. Morgan Stanley raised their stake by roughly 41.9% and own shares priced at $1,076,775,000. Allianz Management upped their position by approximately 884.9% and own shares priced at $342,087,000. Norges Bank promoted their stake, owning $240,913,000 worth of shares. Renaissance Technologies purchased new holdings and own shares priced at $183,107,000. Institutional investors own 51.21% of Moderna stock.

Moderna Inc. is a company dealing with bio-technology. It is responsible for making vaccines based on messenger RNA for various infections and diseases.

Previous articleJohn Tavares Carried To Hospital Following Hit In The Face
Next articleUPS Sees High Volume In Purchase By Stock Traders